Crunch Time, page-69

This crowd couldn’t hit a target with a Hydrogen bomb

The Company Presentation 17th September 2018 which was seven weeksago had recent Upcoming Milestones.

2H 2018 – AM MRSA Clinical Trials Commence

2H 2018 – 510 (K) for US FDA

2H 2018 – US market entry meetings with labs

 

Then on the 31^st October 2018 we get the QuarterlyActivities and cashflow report Just 6 weeks later.

Under future Outlook

“The shipment of an APAS Independence instrument is expected inthe first half of 2019, coinciding with this is the dossier to submit a 510 (K)to the USA FDA for the APAS Independence Instrument ”

SO WHAT THE HELL IS IT

1.      2H 2018 – 510 (K) for US FDA or

2.      1H 2019

It should have been done last year

 

“It isexpected that the development work conducted by Dr Wisplinghoff on the nextanalysis module MRSA will continue”

 

How can this be when they expect to commence MRSA Clinical Trialsthis year

AGAIN SO WHAT THE IS IT

1.            2H 2018 – AMMRSA Clinical Trials Commence or

2.            1H 2019

 

MORE Milestones not Hit, Actually NO milestones Hit.

Im starting to think they are just making stuff up.

Seriously trying to stay positive